ASX:NAN

Nanosonics (NAN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
740,249 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
8.00%
Price Target
N/A
NAN stock logo

About Nanosonics Stock (ASX:NAN)

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories, as well as research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; Nanosonics AuditPro, an infection control workflow compliance management; Trophon EPR for mitigating the risk of exposure to toxic chemicals; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

NAN Stock News Headlines

Pentagon contract could send this $2 AI stock soaring
Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...
Nanosonics Ltd.
Pentagon contract could send this $2 AI stock soaring
Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...
Nanosonics Limited
Nanosonics Limited (NAN.AX)
Wilsons Sticks to Its Hold Rating for Next Science Ltd (NXSCF)
Asian Markets Cheer China's Stimulus
Futures Pointing To Extended Pullback On Wall Street
Nanosonics (NAN) Earnings Dates & Reports
See More Headlines
Receive NAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nanosonics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
482
Year Founded
N/A

Profitability

Net Income
$15.68 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$164.07 million
Book Value
A$0.58 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.61
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Michael C. Kavanagh BSc
    M.B.A., CEO, President, MD & Executive Director
  • Mr. Rod Lopez M.B.A.
    COO & Regional President for Asia Pacific
  • Dr. Steven Farrugia B.E.
    Ph.D., Chief Technology Officer
  • Jason Burriss
    Chief Financial Officer
  • Mr. Sunny Pillai
    Chief Information Officer
  • Mr. Matthew Carbines B.Com.
    L.L.B., General Counsel & Company Secretary
  • Mr. Matthew Lipscombe B.E.
    B.Sc., M.B.A., Chief Marketing Officer
  • Ms. Jodi Sampson M.B.A.
    Chief People & Culture Officer
  • Mr. Vincent Wang
    Head of Global Customer Support & Technical Services
  • Mr. Keith Koby BSEET
    MBA, Senior Vice President of Sales - North America

NAN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Nanosonics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nanosonics investors own include LHC Group (LHCG), Calix (CXL), Aflac (AFL), Appian (APPN), ELMO Software (ELO), Insignia Financial (IFL), Invesco QQQ Trust (QQQ), Questor Technology (QST), Block (SQ) and Axos Financial (AX).

This page (ASX:NAN) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners